Clinical Efficacy of Acellular Dermal Matrix for Soft Tissue Augmentation around Implants: A Systematic Review

Abstract

BACKGROUND: Dental implants offer a reliable therapeutic option for tooth replacement therapy. However, biological, prosthetic and aesthetic complications are not rare events. Adequate width of keratinized gingiva is required for periodontal health and prevention of progressive recession of connective tissue attachments. An insufficient amount of Keratinized Mucosa width (KMW) around dental implants is associated with more plaque accumulation, tissue inflammation, mucosal recession and/or attachment loss. It has been demonstrated that a recently developed acellular dermal matrix can facilitate the regeneration of keratinized gingival tissue around implant. The aim of this review is to determine the clinical efficacy of acellular dermal matrix(ADM) for soft tissue augmentation around implants.

METHODOLOGY: An electronic search of the following databases MEDLINE (NCBI PubMed and PMC), Cochrane Central Register of     Controlled Trials (CCRCT), Science Direct, Google Scholar, EMBASE, EBSCO, K Hub was done along with a hand search of peer reviewed journals for relevant articles. The following combinations of title, abstract, Medical Subject Heading Terms (MeSH) and keywords were used to search through the above-mentioned database. (Keratinized Mucosa Width) AND (Implants) AND (Acellular Dermal Matrix Allograft) AND (Connective tissue graft) AND (Free gingival graft).

RESULTS: A total of 9 articles were included in this systemic review. Acellular dermal matrix was carried out in the included studies as an alternative options to different soft tissue augmentation methods for the treatment of  implants.

CONCLUSION: The use of Acellular Dermal Matrix is a viable alternative to various soft tissue augmentation techniques around implant.